The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

Research output: Contribution to journalArticleAcademicpeer-review

96 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)27-33
Number of pages7
JournalPharmacogenetics
Volume14
DOIs
Publication statusPublished - 2004

Research programs

  • EMC NIHES-01-64-03
  • EMC OR-01-25-01
  • EMC OR-01-34-01

Cite this